Aura Biosciences, Inc. (AURA)
7.29
+0.23
(+3.26%)
USD |
NASDAQ |
Apr 17, 16:00
7.295
0.00 (0.00%)
Pre-Market: 20:00
Aura Biosciences Free Cash Flow : -85.19M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Assertio Holdings, Inc. | -28.18M |
| Olema Pharmaceuticals, Inc. | -146.72M |
| Elicio Therapeutics, Inc. | -36.97M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.47M |
| Cash from Investing (Quarterly) | 29.82M |
| Cash from Financing (Quarterly) | 2.767M |
| Free Cash Flow Per Share (Quarterly) | -0.3247 |
| Free Cash Flow to Equity (Quarterly) | -20.27M |
| Free Cash Flow to Firm (Quarterly) | -20.64M |
| Free Cash Flow Yield | -19.67% |